198 related articles for article (PubMed ID: 27073652)
21. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
[TBL] [Abstract][Full Text] [Related]
23. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
[TBL] [Abstract][Full Text] [Related]
24. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
25. [Idea of Treatment Method for Upper and Lower Rectal Cancer Avoiding Irradiation to Internal and External Sphincter].
Hatano S; Muta Y; Ito T; Chikatani K; Amano K; Ishiguro T; Kumagai Y; Ishibashi K; Yamano T; Nishimura K; Takahashi T; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2021 Feb; 48(2):239-241. PubMed ID: 33597368
[TBL] [Abstract][Full Text] [Related]
26. Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer.
Gómez Del Pulgar T; Cebrián A; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Cruz-Ramos M; Manzarbeitia F; García-Foncillas J
J Cell Mol Med; 2016 Sep; 20(9):1729-36. PubMed ID: 27171907
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of preoperative chemoradiotherapy with S-1 for advanced rectal cancer: a phase II study.
Ushigome M; Funahashi K; Kaneko T; Kagami S; Yoshida K; Miura Y; Koda T; Nagashima Y; Kurihara A; Terahara A
Rep Pract Oncol Radiother; 2023; 28(1):36-46. PubMed ID: 37122915
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
[TBL] [Abstract][Full Text] [Related]
29. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
30. Short-term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE-1).
Kagawa Y; Watanabe J; Uemura M; Ando K; Inoue A; Oba K; Takemasa I; Oki E
Ann Gastroenterol Surg; 2023 Nov; 7(6):968-976. PubMed ID: 37927927
[TBL] [Abstract][Full Text] [Related]
31. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
Fokas E; Allgäuer M; Polat B; Klautke G; Grabenbauer GG; Fietkau R; Kuhnt T; Staib L; Brunner T; Grosu AL; Schmiegel W; Jacobasch L; Weitz J; Folprecht G; Schlenska-Lange A; Flentje M; Germer CT; Grützmann R; Schwarzbach M; Paolucci V; Bechstein WO; Friede T; Ghadimi M; Hofheinz RD; Rödel C;
J Clin Oncol; 2019 Dec; 37(34):3212-3222. PubMed ID: 31150315
[TBL] [Abstract][Full Text] [Related]
32. Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01).
Yeo SG; Oh JH; Kim DY; Baek JY; Kim SY; Park JW; Kim MJ; Chang HJ; Kim TH; Lee JH; Jang HS; Kim JG; Lee MA; Nam TK
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):34-9. PubMed ID: 23265569
[TBL] [Abstract][Full Text] [Related]
33. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
35. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
36. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
[TBL] [Abstract][Full Text] [Related]
37. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
38. Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer.
Larsen FO; Markussen A; Jensen BV; Fromm AL; Vistisen KK; Parner VK; Linnemann D; Hansen RH; Johannesen HH; Schou JV
Clin Colorectal Cancer; 2017 Jun; 16(2):e7-e14. PubMed ID: 27743742
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
[TBL] [Abstract][Full Text] [Related]
40. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]